Open-Label, Randomized, Crossover Study to Estimate the Pharmacokinetics, Bioavailability and Effect of Food on Single Dose Modified-Release Lersivirine (UK-453,061) 500 mg in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 01 Nov 2014
At a glance
- Drugs Lersivirine; Lersivirine
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors Pfizer
- 18 Sep 2012 Actual initiation Date changed from May 2012 to 1 Jun 2012 as reported by ClinicalTrials.gov.
- 30 Aug 2012 Planned End Date changed from 1 Aug 2012 to 1 Sep 2012 as reported by ClinicalTrials.gov.
- 01 Aug 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.